Baseline immune states (BIS) associated with vaccine responsiveness and factors that shape the BIS

Hajj Hussein, 2015, Vaccines through centuries: major cornerstones of global health, Front Public Health, 3, 269, 10.3389/fpubh.2015.00269 Tulchinsky, 2018, Maurice hilleman: creator of vaccines that changed the world, 443 Victora, 2022, Germinal centers, Annu Rev. Immunol., 40, 413, 10.1146/annurev-immunol-120419-022408 Mesin, 2016, Germinal center B cell dynamics, Immunity, 45, 471, 10.1016/j.immuni.2016.09.001 Eisen, 2014, Affinity enhancement of antibodies: how low-affinity antibodies produced early in immune responses are followed by high-affinity antibodies later and in memory B-cell responses, Cancer Immunol. Res, 2, 381, 10.1158/2326-6066.CIR-14-0029 Ueno, 2019, Tfh cell response in influenza vaccines in humans: what is visible and what is invisible, Curr. Opin. Immunol., 59, 9, 10.1016/j.coi.2019.02.007 Tsai, 2014, Follicular helper T-cell memory: establishing new frontiers during antibody response, Immunol. Cell Biol., 92, 57, 10.1038/icb.2013.68 Bentebibel, 2013, Induction of ICOS+CXCR3+CXCR5+ TH cells correlates with antibody responses to influenza vaccination, Sci. Transl. Med, 5, 10.1126/scitranslmed.3005191 Bentebibel, 2016, ICOS(+)PD-1(+)CXCR3(+) T follicular helper cells contribute to the generation of high-avidity antibodies following influenza vaccination, Sci. Rep., 6, 10.1038/srep26494 Pollard, 2021, A guide to vaccinology: from basic principles to new developments, Nat. Rev. Immunol., 21, 83, 10.1038/s41577-020-00479-7 Obermoser, 2013, Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines, Immunity, 38, 831, 10.1016/j.immuni.2012.12.008 Hagan, 2022, Transcriptional atlas of the human immune response to 13 vaccines reveals a common predictor of vaccine-induced antibody responses, Nat. Immunol., 23, 1788, 10.1038/s41590-022-01328-6 Ravichandran, 2023, Distinct baseline immune characteristics associated with responses to conjugated and unconjugated pneumococcal polysaccharide vaccines in older adults, MedRxiv Takeuchi, 2017, CD4 CTL, a cytotoxic subset of CD4+ T cells, their differentiation and function, Front Immunol., 8, 194, 10.3389/fimmu.2017.00194 Zhou, 2011, Age-related changes in memory and effector T cells responding to influenza A/H3N2 and pandemic A/H1N1 strains in humans, Vaccine, 29, 2169, 10.1016/j.vaccine.2010.12.029 Sallusto, 2010, From vaccines to memory and back, Immunity, 33, 451, 10.1016/j.immuni.2010.10.008 Gustafson, 2020, Influence of immune aging on vaccine responses, J. Allergy Clin. Immunol., 145, 1309, 10.1016/j.jaci.2020.03.017 Krammer, 2019, The human antibody response to influenza A virus infection and vaccination, Nat. Rev. Immunol., 19, 383, 10.1038/s41577-019-0143-6 Todryk, 2018, T cell memory to vaccination, Vaccines, 6, 84, 10.3390/vaccines6040084 Lynn, 2022, Modulation of immune responses to vaccination by the microbiota: implications and potential mechanisms, Nat. Rev. Immunol., 22, 33, 10.1038/s41577-021-00554-7 McElhaney, 2012, The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines, Vaccine, 30, 2060, 10.1016/j.vaccine.2012.01.015 Franceschi, 2014, Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases, J. Gerontol. A Biol. Sci. Med Sci., 69, S4, 10.1093/gerona/glu057 Haq, 2014, Immunosenescence: influenza vaccination and the elderly, Curr. Opin. Immunol., 29, 38, 10.1016/j.coi.2014.03.008 Tchkonia, 2013, Cellular senescence and the senescent secretory phenotype: therapeutic opportunities, J. Clin. Invest, 123, 966, 10.1172/JCI64098 Frasca, 2020, Aging induces B cell defects and decreased antibody responses to influenza infection and vaccination, Immun. Ageing, 17, 10.1186/s12979-020-00210-z Mogilenko, 2022, Immune ageing at single-cell resolution, Nat. Rev. Immunol., 22, 484, 10.1038/s41577-021-00646-4 Frasca, 2020, B Cell Immunosenescence, Annu Rev. Cell Dev. Biol., 36, 551, 10.1146/annurev-cellbio-011620-034148 Lee, 2022, Mechanisms underpinning poor antibody responses to vaccines in ageing, Immunol. Lett., 241, 1, 10.1016/j.imlet.2021.11.001 Frasca, 2011, Aging affects human B cell responses, J. Clin. Immunol., 31, 430, 10.1007/s10875-010-9501-7 Frasca, 2008, Aging down-regulates the transcription factor E2A, activation-induced cytidine deaminase, and Ig class switch in human B cells, J. Immunol., 180, 5283, 10.4049/jimmunol.180.8.5283 Frasca, 2011, Age effects on B cells and humoral immunity in humans, Ageing Res Rev., 10, 330, 10.1016/j.arr.2010.08.004 Frasca, 2010, Intrinsic defects in B cell response to seasonal influenza vaccination in elderly humans, Vaccine, 28, 8077, 10.1016/j.vaccine.2010.10.023 Frasca, 2017, Human peripheral late/exhausted memory B cells express a senescent-associated secretory phenotype and preferentially utilize metabolic signaling pathways, Exp. Gerontol., 87, 113, 10.1016/j.exger.2016.12.001 Frasca, 2017, Aging effects on T-bet expression in human B cell subsets, Cell Immunol., 321, 68, 10.1016/j.cellimm.2017.04.007 Colonna-Romano, 2009, A double-negative (IgD-CD27-) B cell population is increased in the peripheral blood of elderly people, Mech. Ageing Dev., 130, 681, 10.1016/j.mad.2009.08.003 Yang, 1996, Relative contribution of T and B cells to hypermutation and selection of the antibody repertoire in germinal centers of aged mice, J. Exp. Med, 183, 959, 10.1084/jem.183.3.959 Zheng, 1997, Immunosenescence and germinal center reaction, Immunol. Rev., 160, 63, 10.1111/j.1600-065X.1997.tb01028.x Burton, 2022, The memory B cell response to influenza vaccination is impaired in older persons, Cell Rep., 41, 10.1016/j.celrep.2022.111613 Silva-Cayetano, 2023, Spatial dysregulation of T follicular helper cells impairs vaccine responses in aging, Nat. Immunol., 10.1038/s41590-023-01519-9 de Bourcy, 2017, Phylogenetic analysis of the human antibody repertoire reveals quantitative signatures of immune senescence and aging, Proc. Natl. Acad. Sci. USA, 114, 1105, 10.1073/pnas.1617959114 Yager, 2008, Age-associated decline in T cell repertoire diversity leads to holes in the repertoire and impaired immunity to influenza virus, J. Exp. Med, 205, 711, 10.1084/jem.20071140 Gil, 2015, Narrowing of human influenza A virus-specific T cell receptor α and β repertoires with increasing age, J. Virol., 89, 4102, 10.1128/JVI.03020-14 Griffiths, 2013, Age-associated increase of low-avidity cytomegalovirus-specific CD8+ T cells that re-express CD45RA, J. Immunol., 190, 5363, 10.4049/jimmunol.1203267 Kumar, 2018, Human T cell development, localization, and function throughout life, Immunity, 48, 202, 10.1016/j.immuni.2018.01.007 Ucar, 2017, The chromatin accessibility signature of human immune aging stems from CD8+ T cells, J. Exp. Med, 214, 3123, 10.1084/jem.20170416 Mogilenko, 2021, Comprehensive profiling of an aging immune system reveals clonal GZMK+ CD8+ T cells as conserved hallmark of inflammaging, Immunity, 54, 99, 10.1016/j.immuni.2020.11.005 Akbar, 2020, Aging immunity may exacerbate COVID-19, Science, 369, 256, 10.1126/science.abb0762 Pereira, 2020, Sestrins induce natural killer function in senescent-like CD8+ T cells, Nat. Immunol., 21, 684, 10.1038/s41590-020-0643-3 Cao, 2010, Age-related alterations of gene expression patterns in human CD8+ T cells, Aging Cell, 9, 19, 10.1111/j.1474-9726.2009.00534.x Harries, 2011, Human aging is characterized by focused changes in gene expression and deregulation of alternative splicing, Aging Cell, 10, 868, 10.1111/j.1474-9726.2011.00726.x Reynolds, 2015, Transcriptomic profiles of aging in purified human immune cells, BMC Genom., 16, 10.1186/s12864-015-1522-4 Poon, 2023, Tissue adaptation and clonal segregation of human memory T cells in barrier sites, Nat. Immunol., 24, 309, 10.1038/s41590-022-01395-9 Zheng, 2016, Blood epigenetic age may predict cancer incidence and mortality, EBioMedicine, 5, 68, 10.1016/j.ebiom.2016.02.008 Martino, 2011, Evidence for age-related and individual-specific changes in DNA methylation profile of mononuclear cells during early immune development in humans, Epigenetics, 6, 1085, 10.4161/epi.6.9.16401 Rakyan, 2010, Human aging-associated DNA hypermethylation occurs preferentially at bivalent chromatin domains, Genome Res, 20, 434, 10.1101/gr.103101.109 Yuan, 2015, An integrative multi-scale analysis of the dynamic DNA methylation landscape in aging, PLoS Genet, 11, 10.1371/journal.pgen.1004996 Tserel, 2015, Age-related profiling of DNA methylation in CD8+ T cells reveals changes in immune response and transcriptional regulator genes, Sci. Rep., 5, 10.1038/srep13107 Moskowitz, 2017, Epigenomics of human CD8 T cell differentiation and aging, Sci. Immunol., 2, 10.1126/sciimmunol.aag0192 Fulop, 2022, Immunosenescence and altered vaccine efficiency in older subjects: a myth difficult to change, Vaccines, 10, 607, 10.3390/vaccines10040607 Fulop, 2023, Immunology of aging: the birth of inflammaging, Clin. Rev. Allergy Immunol., 64, 109, 10.1007/s12016-021-08899-6 Franceschi, 2000, Inflamm-aging. An evolutionary perspective on immunosenescence, Ann. N. Y Acad. Sci., 908, 244, 10.1111/j.1749-6632.2000.tb06651.x Franceschi, 2018, Inflammaging: a new immune-metabolic viewpoint for age-related diseases, Nat. Rev. Endocrinol., 14, 576, 10.1038/s41574-018-0059-4 Hearps, 2012, Aging is associated with chronic innate immune activation and dysregulation of monocyte phenotype and function, Aging Cell, 11, 867, 10.1111/j.1474-9726.2012.00851.x Snodgrass, 2022, Monocyte subsets display age-dependent alterations at fasting and undergo non-age-dependent changes following consumption of a meal, Immun. Ageing, 19, 10.1186/s12979-022-00297-6 Cheung, 2018, Single-cell chromatin modification profiling reveals increased epigenetic variations with aging, Cell, 173, 1385, 10.1016/j.cell.2018.03.079 Qian, 2012, Age-associated elevation in TLR5 leads to increased inflammatory responses in the elderly, Aging Cell, 11, 104, 10.1111/j.1474-9726.2011.00759.x van Duin, 2007, Age-associated defect in human TLR-1/2 function, J. Immunol., 178, 970, 10.4049/jimmunol.178.2.970 De Maeyer, 2021, The impact of ageing on monocytes and macrophages, Immunol. Lett., 230, 1, 10.1016/j.imlet.2020.12.003 Goldberg, 2015, Drivers of age-related inflammation and strategies for healthspan extension, Immunol. Rev., 265, 63, 10.1111/imr.12295 Camell, 2019, Aging induces an nlrp3 inflammasome-dependent expansion of adipose B cells that impairs metabolic homeostasis, Cell Metab., 30, 1024, 10.1016/j.cmet.2019.10.006 Lowsky, 2014, Heterogeneity in healthy aging, J. Gerontol. A Biol. Sci. Med Sci., 69, 640, 10.1093/gerona/glt162 Jylhävä, 2017, Biological age predictors, EBioMedicine, 21, 29, 10.1016/j.ebiom.2017.03.046 Frasca, 2016, Obesity decreases B cell responses in young and elderly individuals, Obes. (Silver Spring), 24, 615, 10.1002/oby.21383 Rutledge, 2022, Measuring biological age using omics data, Nat. Rev. Genet, 23, 715, 10.1038/s41576-022-00511-7 Bell, 2019, DNA methylation aging clocks: challenges and recommendations, Genome Biol., 20, 10.1186/s13059-019-1824-y Alpert, 2019, A clinically meaningful metric of immune age derived from high-dimensional longitudinal monitoring, Nat. Med, 25, 487, 10.1038/s41591-019-0381-y Goudsmit, 2021, Immune age and biological age as determinants of vaccine responsiveness among elderly populations: the Human Immunomics Initiative research program, Eur. J. Epidemiol., 36, 753, 10.1007/s10654-021-00767-z Zhang, 2023, Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbidities, Nat. Immunol., 24, 966, 10.1038/s41590-023-01508-y Klein, 2016, Sex differences in immune responses, Nat. Rev. Immunol., 16, 626, 10.1038/nri.2016.90 Márquez, 2020, Sexual-dimorphism in human immune system aging, Nat. Commun., 11, 10.1038/s41467-020-14396-9 Piasecka, 2018, Distinctive roles of age, sex, and genetics in shaping transcriptional variation of human immune responses to microbial challenges, Proc. Natl. Acad. Sci. USA, 115, E488, 10.1073/pnas.1714765115 Bongen, 2019, Sex differences in the blood transcriptome identify robust changes in immune cell proportions with aging and influenza infection, Cell Rep., 29, 1961, 10.1016/j.celrep.2019.10.019 Scully, 2020, Considering how biological sex impacts immune responses and COVID-19 outcomes, Nat. Rev. Immunol., 20, 442, 10.1038/s41577-020-0348-8 Márquez, 2020, The lethal sex gap: COVID-19, Immun. Ageing, 17, 10.1186/s12979-020-00183-z Zimmermann, 2019, Factors that influence the immune response to vaccination, Clin. Microbiol Rev., 32, 10.1128/CMR.00084-18 Proskovec, 2020, Association of epigenetic metrics of biological age with cortical thickness, JAMA Netw. Open, 3, 10.1001/jamanetworkopen.2020.15428 Hirokawa, 2013, Slower immune system aging in women versus men in the Japanese population, Immun. Ageing, 10, 10.1186/1742-4933-10-19 Horvath, 2016, An epigenetic clock analysis of race/ethnicity, sex, and coronary heart disease, Genome Biol., 17, 10.1186/s13059-016-1030-0 Schmiedel, 2018, Impact of genetic polymorphisms on human immune cell gene expression, Cell, 175, 1701, 10.1016/j.cell.2018.10.022 Libert, 2010, The X chromosome in immune functions: when a chromosome makes the difference, Nat. Rev. Immunol., 10, 594, 10.1038/nri2815 Mousavi, 2020, Escape from X chromosome inactivation and female bias of autoimmune diseases, Mol. Med, 26, 10.1186/s10020-020-00256-1 Crow, 2011, Type I interferonopathies: a novel set of inborn errors of immunity, Ann. N. Y Acad. Sci., 1238, 91, 10.1111/j.1749-6632.2011.06220.x Brown, 2022, TLR7 gain-of-function genetic variation causes human lupus, Nature, 605, 349, 10.1038/s41586-022-04642-z Bakker, 2018, Integration of multi-omics data and deep phenotyping enables prediction of cytokine responses, Nat. Immunol., 19, 776, 10.1038/s41590-018-0121-3 Sparks, 2023, Influenza vaccination reveals sex dimorphic imprints of prior mild COVID-19, Nature, 614, 752, 10.1038/s41586-022-05670-5 Lu, 2021, Multi-omic profiling of primary mouse neutrophils predicts a pattern of sex and age-related functional regulation, Nat. Aging, 1, 715, 10.1038/s43587-021-00086-8 Linnik, 2016, Impact of host genetic polymorphisms on vaccine induced antibody response, Hum. Vaccin Immunother., 12, 907, 10.1080/21645515.2015.1119345 Zhang, 2013, Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals, Nat. Commun., 4 Fernández-Carrillo, 2014, IFNL4 polymorphism predicts response to hepatitis C treatment after liver transplantation, J. Clin. Virol., 61, 282, 10.1016/j.jcv.2014.07.015 Dong, 2015, IL28B genetic variations are associated with treatment response of patients with chronic hepatitis C in a Chinese Han population, J. Dig. Dis., 16, 90, 10.1111/1751-2980.12202 Egli, 2014, IL-28B is a key regulator of B- and T-cell vaccine responses against influenza, PLoS Pathog., 10, 10.1371/journal.ppat.1004556 Ovsyannikova, 2011, The association of CD46, SLAM and CD209 cellular receptor gene SNPs with variations in measles vaccine-induced immune responses: a replication study and examination of novel polymorphisms, Hum. Hered., 72, 206, 10.1159/000331585 Gelder, 2002, Associations between human leukocyte antigens and nonresponsiveness to influenza vaccine, J. Infect. Dis., 185, 114, 10.1086/338014 Franco, 2013, Integrative genomic analysis of the human immune response to influenza vaccination, Elife, 2, 10.7554/eLife.00299 Poland, 2008, Immunogenetics of seasonal influenza vaccine response, Vaccine, 26, D35, 10.1016/j.vaccine.2008.07.065 Kurupati, 2016, Race-related differences in antibody responses to the inactivated influenza vaccine are linked to distinct pre-vaccination gene expression profiles in blood, Oncotarget, 7, 62898, 10.18632/oncotarget.11704 Williams, 2016, I too, am America: a review of research on systemic lupus erythematosus in African-Americans, Lupus Sci. Med, 3, 10.1136/lupus-2015-000144 Ovsyannikova, 2012, Genome-wide association study of antibody response to smallpox vaccine, Vaccine, 30, 4182, 10.1016/j.vaccine.2012.04.055 Sanz, 2018, Genetic and evolutionary determinants of human population variation in immune responses, Curr. Opin. Genet Dev., 53, 28, 10.1016/j.gde.2018.06.009 Nédélec, 2016, Genetic ancestry and natural selection drive population differences in immune responses to pathogens, Cell, 167, 657, 10.1016/j.cell.2016.09.025 Barreiro, 2012, Deciphering the genetic architecture of variation in the immune response to mycobacterium tuberculosis infection, Proc. Natl. Acad. Sci. USA, 109, 1204, 10.1073/pnas.1115761109 Wang, 2018, An atlas of genetic variation linking pathogen-induced cellular traits to human disease, Cell Host Microbe, 24, 308, 10.1016/j.chom.2018.07.007 Lee, 2014, Common genetic variants modulate pathogen-sensing responses in human dendritic cells, Science, 343, 10.1126/science.1246980 Randolph, 2021, Genetic ancestry effects on the response to viral infection are pervasive but cell type specific, Science, 374, 1127, 10.1126/science.abg0928 Netea, 2011, Trained immunity: a memory for innate host defense, Cell Host Microbe, 9, 355, 10.1016/j.chom.2011.04.006 Netea, 2011, Trained immunity: a memory for innate host defense, Cell Host Microbe, 9, 355, 10.1016/j.chom.2011.04.006 Netea, 2020, Defining trained immunity and its role in health and disease, Nat. Rev. Immunol., 20, 375, 10.1038/s41577-020-0285-6 Kaufmann, 2018, BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis, Cell, 172, 176, 10.1016/j.cell.2017.12.031 van ’t Wout, 1992, The role of BCG/PPD-activated macrophages in resistance against systemic candidiasis in mice, Scand. J. Immunol., 36, 713, 10.1111/j.1365-3083.1992.tb03132.x Tribouley, 1978, Effect of Bacillus Callmette Guerin (BCG) on the receptivity of nude mice to Schistosoma mansoni, C. R. Seances Soc. Biol. Fil., 172, 902 Bistoni, 1986, Evidence for macrophage-mediated protection against lethal Candida albicans infection, Infect. Immun., 51, 668, 10.1128/iai.51.2.668-674.1986 Cheong, 2022, Epigenetic memory of COVID-19 in innate immune cells and their progenitors, Immunology Wimmers, 2020, Emerging technologies for systems vaccinology - multi-omics integration and single-cell (epi)genomic profiling, Curr. Opin. Immunol., 65, 57, 10.1016/j.coi.2020.05.001 Lee, 2022, Epigenetic adjuvants: durable reprogramming of the innate immune system with adjuvants, Curr. Opin. Immunol., 77, 10.1016/j.coi.2022.102189 Wimmers, 2021, The single-cell epigenomic and transcriptional landscape of immunity to influenza vaccination, Cell, 184, 3915, 10.1016/j.cell.2021.05.039 Nikolich-Žugich, 2017, Cytomegalovirus (CMV) research in immune senescence comes of age: overview of the 6th International Workshop on CMV and Immunosenescence, Geroscience, 39, 245, 10.1007/s11357-017-9984-8 Pawelec, 2011, Role of CMV in immune senescence, Virus Res, 157, 175, 10.1016/j.virusres.2010.09.010 Ouyang, 2003, Large numbers of dysfunctional CD8+ T lymphocytes bearing receptors for a single dominant CMV epitope in the very old, J. Clin. Immunol., 23, 247, 10.1023/A:1024580531705 Ouyang, 2003, An age-related increase in the number of CD8+ T cells carrying receptors for an immunodominant Epstein-Barr virus (EBV) epitope is counteracted by a decreased frequency of their antigen-specific responsiveness, Mech. Ageing Dev., 124, 477, 10.1016/S0047-6374(03)00026-5 van den Berg, 2019, The hallmarks of CMV-specific CD8 T-cell differentiation, Med Microbiol Immunol., 208, 365, 10.1007/s00430-019-00608-7 Chen, 2001, CD8 T cells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infection, Blood, 98, 156, 10.1182/blood.V98.1.156 Kuijpers, 2003, Frequencies of circulating cytolytic, CD45RA+CD27-, CD8+ T lymphocytes depend on infection with CMV, J Immunol, 170, 4342 Appay, 2002, Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections, Nat. Med, 8, 379, 10.1038/nm0402-379 Champagne, 2001, Skewed maturation of memory HIV-specific CD8 T lymphocytes, Nature, 410, 106, 10.1038/35065118 Furman, 2015, Cytomegalovirus infection enhances the immune response to influenza, Sci. Transl. Med, 7, 10.1126/scitranslmed.aaa2293 van den Berg, 2019, Effect of latent cytomegalovirus infection on the antibody response to influenza vaccination: a systematic review and meta-analysis, Med Microbiol Immunol., 208, 305, 10.1007/s00430-019-00602-z Querec, 2006, Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity, J. Exp. Med, 203, 413, 10.1084/jem.20051720 Querec, 2009, Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans, Nat. Immunol., 10, 116, 10.1038/ni.1688 WHO, 2018 Thompson, 2003, Mortality associated with influenza and respiratory syncytial virus in the United States, JAMA, 289, 179, 10.1001/jama.289.2.179 Grohskopf, 2022, Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices - United States, 2022-23 Influenza Season, MMWR Recomm. Rep., 71, 1, 10.15585/mmwr.rr7101a1 2010, Licensure of a high-dose inactivated influenza vaccine for persons aged >or=65 years (Fluzone High-Dose) and guidance for use - United States, 2010, MMWR Morb. Mortal. Wkly Rep., 59, 485 Smallman, 1989, Cryptococcosis of the larynx, J. Laryngol. Otol., 103, 214, 10.1017/S0022215100108497 Treanor, 2007, Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trial, JAMA, 297, 1577, 10.1001/jama.297.14.1577 Kavian, 2020, Assessment of enhanced influenza vaccination finds that FluAd conveys an advantage in mice and older adults, Clin. Transl. Immunol., 9, 10.1002/cti2.1107 Podda, 2001, The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine, Vaccine, 19, 2673, 10.1016/S0264-410X(00)00499-0 McLean, 2023, Interim estimates of 2022-23 seasonal influenza vaccine effectiveness - Wisconsin, October 2022-February 2023, MMWR Morb. Mortal. Wkly Rep., 72, 201, 10.15585/mmwr.mm7208a1 Fonseca, 1991, [Myocardiopathy caused by Portuguese-type familial amyloidotic polyneuropathy. Sequential morphologic and functional study of 60 patients, Rev. Port. Cardiol., 10, 909 Becker, 2021, Influenza vaccines: successes and continuing challenges, J. Infect. Dis., 224, S405, 10.1093/infdis/jiab269 Bucasas, 2011, Early patterns of gene expression correlate with the humoral immune response to influenza vaccination in humans, J. Infect. Dis., 203, 921, 10.1093/infdis/jiq156 Nakaya, 2011, Systems biology of vaccination for seasonal influenza in humans, Nat. Immunol., 12, 786, 10.1038/ni.2067 Stoeckius, 2017, Simultaneous epitope and transcriptome measurement in single cells, Nat. Methods, 14, 865, 10.1038/nmeth.4380 Tsang, 2014, Global analyses of human immune variation reveal baseline predictors of postvaccination responses, Cell, 157, 499, 10.1016/j.cell.2014.03.031 Kotliarov, 2020, Broad immune activation underlies shared set point signatures for vaccine responsiveness in healthy individuals and disease activity in patients with lupus, Nat. Med, 26, 618, 10.1038/s41591-020-0769-8 Banchereau, 2016, Personalized immunomonitoring uncovers molecular networks that stratify lupus patients, Cell, 165, 1548, 10.1016/j.cell.2016.05.057 Tsang, 2020, Improving vaccine-induced immunity: can baseline predict outcome?, Trends Immunol., 41, 457, 10.1016/j.it.2020.04.001 Zimmermann, 2017, Integration of immune cell populations, mRNA-Seq, and CpG methylation to better predict humoral immunity to influenza vaccination: dependence of mRNA-Seq/CpG methylation on immune cell populations, Front Immunol., 8, 10.3389/fimmu.2017.00445 Forst, 2022, Vaccination history, body mass index, age, and baseline gene expression predict influenza vaccination outcomes, Viruses, 14, 2446, 10.3390/v14112446 Riese, 2022, Distinct immunological and molecular signatures underpinning influenza vaccine responsiveness in the elderly, Nat. Commun., 13, 10.1038/s41467-022-34487-z Lynn, 2018, The potential of the microbiota to influence vaccine responses, J. Leukoc. Biol., 103, 225, 10.1189/jlb.5MR0617-216R Oh, 2014, TLR5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccination, Immunity, 41, 478, 10.1016/j.immuni.2014.08.009 Hagan, 2019, Antibiotics-driven gut microbiome perturbation alters immunity to vaccines in humans, Cell, 178, 1313, 10.1016/j.cell.2019.08.010 Gensous, 2018, Responders and non-responders to influenza vaccination: a DNA methylation approach on blood cells, Exp. Gerontol., 105, 94, 10.1016/j.exger.2018.01.019 2017, Multicohort analysis reveals baseline transcriptional predictors of influenza vaccination responses, Sci. Immunol., 2 Fourati, 2022, Pan-vaccine analysis reveals innate immune endotypes predictive of antibody responses to vaccination, Nat. Immunol., 23, 1777, 10.1038/s41590-022-01329-5 Pereira, 2020, Targeting inflammation and immunosenescence to improve vaccine responses in the elderly, Front Immunol., 11, 10.3389/fimmu.2020.583019 Vukmanovic-Stejic, 2018, Enhancement of cutaneous immunity during aging by blocking p38 mitogen-activated protein (MAP) kinase-induced inflammation, J. Allergy Clin. Immunol., 142, 844, 10.1016/j.jaci.2017.10.032 Bartholomeus, 2018, Transcriptome profiling in blood before and after hepatitis B vaccination shows significant differences in gene expression between responders and non-responders, Vaccine, 36, 6282, 10.1016/j.vaccine.2018.09.001 Fourati, 2016, Pre-vaccination inflammation and B-cell signalling predict age-related hyporesponse to hepatitis B vaccination, Nat. Commun., 7, 10.1038/ncomms10369 Wang, 2022, Single-cell transcriptomic atlas reveals distinct immunological responses between COVID-19 vaccine and natural SARS-CoV-2 infection, J. Med Virol., 94, 5304, 10.1002/jmv.28012 Lozano-Rodríguez, 2022, Cellular and humoral functional responses after BNT162b2 mRNA vaccination differ longitudinally between naïve and subjects recovered from COVID-19, Cell Rep., 38, 10.1016/j.celrep.2021.110235 Ludwikowska, 2023, COVID-19 mRNA BNT162b2 vaccine safety and B-cell and T-cell reactogenicity among children with a history of paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS-TS) - preliminary study, Vaccine, 41, 2289, 10.1016/j.vaccine.2023.02.072 Atyeo, 2021, COVID-19 mRNA vaccines drive differential antibody Fc-functional profiles in pregnant, lactating, and nonpregnant women, Sci. Transl. Med, 13, 10.1126/scitranslmed.abi8631 Zhang, 2022, Humoral and cellular immune memory to four COVID-19 vaccines, Cell, 185, 2434, 10.1016/j.cell.2022.05.022 Cerqueira-Silva, 2022, Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study, Lancet Infect. Dis., 22, 791, 10.1016/S1473-3099(22)00140-2 Wang, 2023, Longitudinal proteomic investigation of COVID-19 vaccination, Protein Cell, 10.1093/procel/pwad004 Polack, 2020, Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine, N. Engl. J. Med, 383, 2603, 10.1056/NEJMoa2034577 Hägg, 2022, COVID vaccination in older adults, Nat. Microbiol, 7, 1106, 10.1038/s41564-022-01166-0 Mues, 2022, Real-world comparative effectiveness of mRNA-1273 and BNT162b2 vaccines among immunocompromised adults identified in administrative claims data in the United States, Vaccine, 40, 6730, 10.1016/j.vaccine.2022.09.025 Boulouis, 2022, MAIT cell compartment characteristics are associated with the immune response magnitude to the BNT162b2 mRNA anti-SARS-CoV-2 vaccine, Mol. Med, 28, 10.1186/s10020-022-00484-7 Robinson, 2001, C.G. Whitney, Active Bacterial Core Surveillance (ABCs)/Emerging Infections Program Network, Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: opportunities for prevention in the conjugate vaccine era, JAMA, 285, 1729, 10.1001/jama.285.13.1729 Novak, 1999, Pathogenesis of pneumococcal pneumonia, Semin Respir. Infect., 14, 209 Huang, 2011, Healthcare utilization and cost of pneumococcal disease in the United States, Vaccine, 29, 3398, 10.1016/j.vaccine.2011.02.088 McCool, 1999, B- and T-cell immune responses to pneumococcal conjugate vaccines: divergence between carrier- and polysaccharide-specific immunogenicity, Infect. Immun., 67, 4862, 10.1128/IAI.67.9.4862-4869.1999 Mond, 1995, T cell-independent antigens type 2, Annu Rev. Immunol., 13, 655, 10.1146/annurev.iy.13.040195.003255 Hayward, 2016, Is 13-valent pneumococcal conjugate vaccine (PCV13) combined With 23-valent pneumococcal polysaccharide vaccine (PPSV23) superior to PPSV23 alone for reducing incidence or severity of pneumonia in older adults? A Clin-IQ, J. Patient Cent. Res Rev., 3, 111, 10.17294/2330-0698.1214 Darkes, 2002, Pneumococcal conjugate vaccine (Prevnar; PNCRM7): a review of its use in the prevention of Streptococcus pneumoniae infection, Paediatr. Drugs, 4, 609, 10.2165/00128072-200204090-00005 Mishra, 2018, Structural and immunological characterization of E. coli derived recombinant CRM197 protein used as carrier in conjugate vaccines, Biosci. Rep., 38, 10.1042/BSR20180238 Sterrett, 2020, Peripheral CD4 T follicular cells induced by a conjugated pneumococcal vaccine correlate with enhanced opsonophagocytic antibody responses in younger individuals, Vaccine, 38, 1778, 10.1016/j.vaccine.2019.12.023 Jackson, 2013, Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naïve adults, Vaccine, 31, 3577, 10.1016/j.vaccine.2013.04.085 Moore, 2016, Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control study, Lancet Respir. Med, 4, 399, 10.1016/S2213-2600(16)00052-7 McLaughlin, 2018, Effectiveness of 13-valent pneumococcal conjugate vaccine against hospitalization for community-acquired pneumonia in older US adults: a test-negative design, Clin. Infect. Dis., 67, 1498 Kraicer-Melamed, 2016, The effectiveness of pneumococcal polysaccharide vaccine 23 (PPV23) in the general population of 50 years of age and older: a systematic review and meta-analysis, Vaccine, 34, 1540, 10.1016/j.vaccine.2016.02.024 Lipsitch, 2018, Serotype-specific immune responses to pneumococcal conjugate vaccine among children are significantly correlated by individual: analysis of randomized controlled trial data, Vaccine, 36, 473, 10.1016/j.vaccine.2017.12.015 Song, 2013, Pneumococcal vaccine and opsonic pneumococcal antibody, J. Infect. Chemother., 19, 412, 10.1007/s10156-013-0601-1 LaFon, 2018, Measuring immune responses to pneumococcal vaccines, J. Immunol. Methods, 461, 37, 10.1016/j.jim.2018.08.002 Rabian, 2010, Cellular CD4 T cell responses to the diphtheria-derived carrier protein of conjugated pneumococcal vaccine and antibody response to pneumococcal vaccination in HIV-infected adults, Clin. Infect. Dis., 50, 1174, 10.1086/651418 Pischedda, 2021, Changes in epigenetic profiles throughout early childhood and their relationship to the response to pneumococcal vaccination, Clin. Epigenetics, 13, 10.1186/s13148-021-01012-w Vanderven, 2017, Antibody-dependent cellular cytotoxicity responses to seasonal influenza vaccination in older adults, J. Infect. Dis., 217, 12, 10.1093/infdis/jix554 Davies, 2022, Polysaccharide and conjugate vaccines to Streptococcus pneumoniae generate distinct humoral responses, Sci. Transl. Med, 14, 10.1126/scitranslmed.abm4065 Laoprasopwattana, 2007, Antibody-dependent cellular cytotoxicity mediated by plasma obtained before secondary dengue virus infections: potential involvement in early control of viral replication, J. Infect. Dis., 195, 1108, 10.1086/512860 Liu, 2017, Antibody-dependent-cellular-cytotoxicity-inducing antibodies significantly affect the post-exposure treatment of Ebola virus infection, Sci. Rep., 7 Kristensen, 2016, Antibody responses with Fc-mediated functions after vaccination of hiv-infected subjects with trivalent influenza vaccine, J. Virol., 90, 5724, 10.1128/JVI.00285-16 Kazmin, 2017, Systems analysis of protective immune responses to RTS,S malaria vaccination in humans, Proc. Natl. Acad. Sci. USA, 114, 2425, 10.1073/pnas.1621489114 Muyanja, 2014, Immune activation alters cellular and humoral responses to yellow fever 17D vaccine, J. Clin. Invest, 124, 3147, 10.1172/JCI75429 Waggoner, 2011, Natural killer cells act as rheostats modulating antiviral T cells, Nature, 481, 394, 10.1038/nature10624 Cox, 2021, Targeting natural killer cells to enhance vaccine responses, Trends Pharm. Sci., 42, 789, 10.1016/j.tips.2021.06.004 Poolman, 2011, Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines, Expert Rev. Vaccin., 10, 307, 10.1586/erv.11.8 Hammer, 2018, Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells, Nat. Immunol., 19, 453, 10.1038/s41590-018-0082-6 Ali, 2021, Natural killer cell immunosuppressive function requires CXCR3-dependent redistribution within lymphoid tissues, J. Clin. Invest, 131, 10.1172/JCI146686 Peppa, 2013, Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion, J. Exp. Med, 210, 99, 10.1084/jem.20121172 Malaria, The WHO. (2023). 〈https://www.who.int/news-room/fact-sheets/detail/malaria〉 (accessed June 6, 2023). Praet, 2022, Assessing the safety, impact and effectiveness of RTS,S/AS01E malaria vaccine following its introduction in three sub-Saharan African countries: methodological approaches and study set-up, Malar. J., 21, 10.1186/s12936-022-04144-3 Nadeem, 2022, Mosquirix™ RTS, S/AS01 Vaccine Development, Immunogenicity, and Efficacy, Vaccines, 10, 713, 10.3390/vaccines10050713 Warimwe, 2013, Peripheral blood monocyte-to-lymphocyte ratio at study enrollment predicts efficacy of the RTS,S malaria vaccine: analysis of pooled phase II clinical trial data, BMC Med, 11, 10.1186/1741-7015-11-184 Moncunill, 2020, Antigen-stimulated PBMC transcriptional protective signatures for malaria immunization, Sci. Transl. Med, 12, 10.1126/scitranslmed.aay8924 Neal, 2022, Preimmunization correlates of protection shared across malaria vaccine trials in adults, NPJ Vaccin., 7, 10.1038/s41541-021-00425-1 DiazGranados, 2014, Efficacy of high-dose versus standard-dose influenza vaccine in older adults, N. Engl. J. Med, 371, 635, 10.1056/NEJMoa1315727 Pulendran, 2021, Emerging concepts in the science of vaccine adjuvants, Nat. Rev. Drug Discov., 20, 454, 10.1038/s41573-021-00163-y Di Pasquale, 2015, Vaccine adjuvants: from 1920 to 2015 and beyond, Vaccines, 3, 320, 10.3390/vaccines3020320 Yang, 2022, Recent advances in the development of toll-like receptor agonist-based vaccine adjuvants for infectious diseases, Pharmaceutics, 14, 423, 10.3390/pharmaceutics14020423 Lal, 2015, Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults, N. Engl. J. Med, 372, 2087, 10.1056/NEJMoa1501184 Leroux-Roels, 2010, Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study, Vaccine, 28, 849, 10.1016/j.vaccine.2009.10.017 Seubert, 2008, The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells, J. Immunol., 180, 5402, 10.4049/jimmunol.180.8.5402 Mulligan, 2014, Serological responses to an avian influenza A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial, JAMA, 312, 1409, 10.1001/jama.2014.12854 Coleman, 2021, Effectiveness of the MF59-adjuvanted trivalent or quadrivalent seasonal influenza vaccine among adults 65 years of age or older, a systematic review and meta-analysis, Influenza Other Respir. Virus, 15, 813, 10.1111/irv.12871 Frey, 2014, Comparison of the safety and immunogenicity of an MF59®-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects, Vaccine, 32, 5027, 10.1016/j.vaccine.2014.07.013 Anderson, 2020, Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults, N. Engl. J. Med, 383, 2427, 10.1056/NEJMoa2028436 Herrero, 2001, IFN-gamma-dependent transcription of MHC class II IA is impaired in macrophages from aged mice, J. Clin. Invest, 107, 485, 10.1172/JCI11696 Dose-Finding Trial to Evaluate the Safety and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647 in Healthy Adults, NIH Clinical Trials, n.d. 〈https://classic.clinicaltrials.gov/ct2/show/NCT04232280〉 (accessed June 25, 2023). Treanor, 2020, A phase 2 study of the bivalent VLP norovirus vaccine candidate in older adults; impact of MPL adjuvant or a second dose, Vaccine, 38, 5842, 10.1016/j.vaccine.2020.06.011 Alvarez, 2022, A hemagglutinin 1 carrying plant-based virus-like particle vaccine generates an efficacious cellular response by exploiting IL-1 signaling in both adult and aged mice, Immunohorizons, 6, 384, 10.4049/immunohorizons.2200036 Ramasamy, 2021, Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial, Lancet, 396, 1979, 10.1016/S0140-6736(20)32466-1 Geckin, 2022, Trained immunity: implications for vaccination, Curr. Opin. Immunol., 77, 10.1016/j.coi.2022.102190 Mulè, 2023, Multiscale integration of human and single-cell variations reveals unadjuvanted vaccine high responders are naturally adjuvanted, MedRxiv Rinchai, 2022, High-temporal resolution profiling reveals distinct immune trajectories following the first and second doses of COVID-19 mRNA vaccines, Sci. Adv., 8, 10.1126/sciadv.abp9961 Arunachalam, 2021, Systems vaccinology of the BNT162b2 mRNA vaccine in humans, Nature, 596, 410, 10.1038/s41586-021-03791-x Pang, 2022, Longitudinal study of DNA methylation and epigenetic clocks prior to and following test-confirmed COVID-19 and mRNA vaccination, Front Genet, 13, 10.3389/fgene.2022.819749 Zimmermann, 2018, The influence of the intestinal microbiome on vaccine responses, Vaccine, 36, 4433, 10.1016/j.vaccine.2018.04.066 Belkaid, 2014, Role of the microbiota in immunity and inflammation, Cell, 157, 121, 10.1016/j.cell.2014.03.011 Booth, 2016, The aging epigenome, Mol. Cell, 62, 728, 10.1016/j.molcel.2016.05.013 Ridker, 2017, Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease, N. Engl. J. Med, 377, 1119, 10.1056/NEJMoa1707914 Banerjee, 2003, Modulation of inflammatory mediators by ibuprofen and curcumin treatment during chronic inflammation in rat, Immunopharmacol. Immunotoxicol., 25, 213, 10.1081/IPH-120020471 Lang Kuhs, 2015, Association between regular aspirin use and circulating markers of inflammation: a study within the prostate, lung, colorectal, and ovarian cancer screening trial, Cancer Epidemiol. Biomark. Prev., 24, 825, 10.1158/1055-9965.EPI-14-1363 Meyer-Lindemann, 2023, The impact of exercise on immunity, metabolism, and atherosclerosis, Int J. Mol. Sci., 24, 3394, 10.3390/ijms24043394 Simpson, 2015, Exercise and the regulation of immune functions, Prog. Mol. Biol. Transl. Sci., 135, 355, 10.1016/bs.pmbts.2015.08.001 Kohut, 2004, Moderate exercise improves antibody response to influenza immunization in older adults, Vaccine, 22, 2298, 10.1016/j.vaccine.2003.11.023 Woods, 2009, Cardiovascular exercise training extends influenza vaccine seroprotection in sedentary older adults: the immune function intervention trial, J. Am. Geriatr. Soc., 57, 2183, 10.1111/j.1532-5415.2009.02563.x Stallone, 2019, mTOR and aging: an old fashioned dress, Int J. Mol. Sci., 20, 2774, 10.3390/ijms20112774 Green, 2022, Molecular mechanisms of dietary restriction promoting health and longevity, Nat. Rev. Mol. Cell Biol., 23, 56, 10.1038/s41580-021-00411-4 Rickman, 2011, The CALERIE Study: design and methods of an innovative 25% caloric restriction intervention, Conte Clin. Trials, 32, 874, 10.1016/j.cct.2011.07.002 Dorling, 2021, Effects of caloric restriction on human physiological, psychological, and behavioral outcomes: highlights from CALERIE phase 2, Nutr. Rev., 79, 98, 10.1093/nutrit/nuaa085 Lamming, 2013, Rapalogs and mTOR inhibitors as anti-aging therapeutics, J. Clin. Invest, 123, 980, 10.1172/JCI64099 Martel, 1977, Inhibition of the immune response by rapamycin, a new antifungal antibiotic, Can. J. Physiol. Pharm., 55, 48, 10.1139/y77-007 Mannick, 2014, mTOR inhibition improves immune function in the elderly, Sci. Transl. Med, 6, 10.1126/scitranslmed.3009892 Mannick, 2023, Targeting the biology of aging with mTOR inhibitors, Nat. Aging, 10.1038/s43587-023-00416-y Diaz, 2017, Metformin improves in vivo and in vitro B cell function in individuals with obesity and type-2 diabetes, Vaccine, 35, 2694, 10.1016/j.vaccine.2017.03.078 Kulkarni, 2020, Benefits of metformin in attenuating the hallmarks of aging, Cell Metab., 32, 15, 10.1016/j.cmet.2020.04.001 Saleh, 2022, Senolytic therapy: a potential approach for the elimination of oncogene-induced senescent HPV-positive cells, Int J. Mol. Sci., 23, 15512, 10.3390/ijms232415512 Farr, 2017, Targeting cellular senescence prevents age-related bone loss in mice, Nat. Med, 23, 1072, 10.1038/nm.4385 Fahy, 2019, Reversal of epigenetic aging and immunosenescent trends in humans, Aging Cell, 18, 10.1111/acel.13028 Xie, 2021, Ontology-based precision vaccinology for deep mechanism understanding and precision vaccine development, Curr. Pharm. Des., 27, 900, 10.2174/1381612826666201125112131